Novo Integrated Sciences, Inc. (NVOS)
USD 0.07
(2.79%)
USD 0.07
(2.79%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 35.56 Million USD | -12.99% |
| 2022 | 40.87 Million USD | -34.03% |
| 2021 | 61.95 Million USD | 75.07% |
| 2020 | 35.39 Million USD | 9.66% |
| 2019 | 32.27 Million USD | 580.43% |
| 2018 | 4.74 Million USD | -13.99% |
| 2017 | 5.51 Million USD | 7796.88% |
| 2016 | 69.83 Thousand USD | 150.53% |
| 2015 | 27.87 Thousand USD | 23.38% |
| 2014 | 22.59 Thousand USD | -93.68% |
| 2013 | 357.71 Thousand USD | 935.79% |
| 2012 | 34.53 Thousand USD | 33.8% |
| 2011 | 25.81 Thousand USD | -97.83% |
| 2010 | 1.18 Million USD | 90.91% |
| 2009 | 621.8 Thousand USD | 2984.63% |
| 2008 | 20.15 Thousand USD | -44.33% |
| 2007 | 36.2 Thousand USD | 882.87% |
| 2006 | 3684.00 USD | -75.92% |
| 2005 | 15.29 Thousand USD | -86.46% |
| 2004 | 112.95 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 35.32 Million USD | 1.08% |
| 2024 Q1 | 37.24 Million USD | 4.73% |
| 2024 Q2 | 34.94 Million USD | -6.16% |
| 2023 Q2 | 36.48 Million USD | -3.34% |
| 2023 Q1 | 37.74 Million USD | -7.64% |
| 2023 FY | 35.56 Million USD | -12.99% |
| 2023 Q3 | 35.74 Million USD | -2.04% |
| 2023 Q4 | 35.56 Million USD | -0.51% |
| 2022 Q2 | 70.32 Million USD | 9.99% |
| 2022 Q4 | 40.87 Million USD | -43.07% |
| 2022 FY | 40.87 Million USD | -34.03% |
| 2022 Q1 | 63.93 Million USD | 3.19% |
| 2022 Q3 | 71.79 Million USD | 2.09% |
| 2021 FY | 61.95 Million USD | 75.07% |
| 2021 Q3 | 42.22 Million USD | 21.15% |
| 2021 Q4 | 61.95 Million USD | 46.72% |
| 2021 Q1 | 34.83 Million USD | -1.57% |
| 2021 Q2 | 34.85 Million USD | 0.06% |
| 2020 Q2 | 36.63 Million USD | 14.13% |
| 2020 Q4 | 35.39 Million USD | -3.23% |
| 2020 FY | 35.39 Million USD | 9.66% |
| 2020 Q3 | 36.57 Million USD | -0.18% |
| 2020 Q1 | 32.1 Million USD | -0.52% |
| 2019 FY | 32.27 Million USD | 580.43% |
| 2019 Q1 | 5.06 Million USD | 6.73% |
| 2019 Q2 | 29.08 Million USD | 474.47% |
| 2019 Q3 | 31.68 Million USD | 8.94% |
| 2019 Q4 | 32.27 Million USD | 1.87% |
| 2018 Q4 | 4.74 Million USD | -2.0% |
| 2018 Q3 | 4.84 Million USD | -4.57% |
| 2018 Q2 | 5.07 Million USD | 2.3% |
| 2018 Q1 | 4.95 Million USD | -10.09% |
| 2018 FY | 4.74 Million USD | -13.99% |
| 2017 Q1 | 69.83 Thousand USD | 162.91% |
| 2017 Q4 | 5.51 Million USD | 2.33% |
| 2017 Q3 | 5.38 Million USD | 14292.86% |
| 2017 Q2 | 37.44 Thousand USD | -46.38% |
| 2017 FY | 5.51 Million USD | 7796.88% |
| 2016 FY | 69.83 Thousand USD | 150.53% |
| 2016 Q2 | 47.25 Thousand USD | 69.53% |
| 2016 Q3 | 31.21 Thousand USD | -33.94% |
| 2016 Q4 | 26.56 Thousand USD | -14.91% |
| 2016 Q1 | 27.87 Thousand USD | 23.98% |
| 2015 FY | 27.87 Thousand USD | 23.38% |
| 2015 Q3 | 22.02 Thousand USD | -23.3% |
| 2015 Q1 | 22.59 Thousand USD | -83.07% |
| 2015 Q2 | 28.71 Thousand USD | 27.09% |
| 2015 Q4 | 22.48 Thousand USD | 2.09% |
| 2014 FY | 22.59 Thousand USD | -93.68% |
| 2014 Q3 | 200.61 Thousand USD | -32.04% |
| 2014 Q1 | 357.71 Thousand USD | -5.54% |
| 2014 Q4 | 133.46 Thousand USD | -33.47% |
| 2014 Q2 | 295.17 Thousand USD | -17.48% |
| 2013 FY | 357.71 Thousand USD | 935.79% |
| 2013 Q4 | 378.71 Thousand USD | 1628.83% |
| 2013 Q3 | 21.9 Thousand USD | -55.5% |
| 2013 Q2 | 49.22 Thousand USD | 42.54% |
| 2013 Q1 | 34.53 Thousand USD | -87.44% |
| 2012 Q4 | 274.93 Thousand USD | 0.5% |
| 2012 Q2 | 226.08 Thousand USD | 775.89% |
| 2012 Q1 | 25.81 Thousand USD | -84.3% |
| 2012 FY | 34.53 Thousand USD | 33.8% |
| 2012 Q3 | 273.56 Thousand USD | 21.0% |
| 2011 Q4 | 164.45 Thousand USD | -7.75% |
| 2011 Q2 | 1.15 Million USD | -2.88% |
| 2011 Q1 | 1.18 Million USD | 148.44% |
| 2011 Q3 | 178.25 Thousand USD | -84.54% |
| 2011 FY | 25.81 Thousand USD | -97.83% |
| 2010 Q1 | 621.8 Thousand USD | 102.68% |
| 2010 FY | 1.18 Million USD | 90.91% |
| 2010 Q4 | 477.8 Thousand USD | 1.72% |
| 2010 Q3 | 469.72 Thousand USD | -49.04% |
| 2010 Q2 | 921.77 Thousand USD | 48.24% |
| 2009 Q4 | 306.79 Thousand USD | 385.45% |
| 2009 FY | 621.8 Thousand USD | 2984.63% |
| 2009 Q1 | 20.15 Thousand USD | -76.53% |
| 2009 Q2 | 83.93 Thousand USD | 316.4% |
| 2009 Q3 | 63.19 Thousand USD | -24.71% |
| 2008 Q4 | 85.89 Thousand USD | -28.69% |
| 2008 Q1 | 36.2 Thousand USD | -56.19% |
| 2008 Q2 | 27.99 Thousand USD | -22.69% |
| 2008 FY | 20.15 Thousand USD | -44.33% |
| 2008 Q3 | 120.44 Thousand USD | 330.29% |
| 2007 Q2 | 83.44 Thousand USD | 2165.17% |
| 2007 Q4 | 82.64 Thousand USD | 120.36% |
| 2007 Q1 | 3684.00 USD | -86.78% |
| 2007 Q3 | 37.5 Thousand USD | -55.06% |
| 2007 FY | 36.2 Thousand USD | 882.87% |
| 2006 FY | 3684.00 USD | -75.92% |
| 2006 Q4 | 27.86 Thousand USD | -73.79% |
| 2006 Q3 | 106.29 Thousand USD | 871.3% |
| 2006 Q2 | 10.94 Thousand USD | -28.45% |
| 2006 Q1 | 15.29 Thousand USD | 561.02% |
| 2005 FY | 15.29 Thousand USD | -86.46% |
| 2005 Q2 | 100.18 Thousand USD | 0.0% |
| 2005 Q3 | 19.76 Thousand USD | -80.27% |
| 2005 Q4 | 2314.00 USD | -88.29% |
| 2004 FY | 112.95 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 5.35 Billion USD | 99.336% |
| Addus HomeCare Corporation | 1.02 Billion USD | 96.528% |
| AirSculpt Technologies, Inc. | 213.55 Million USD | 83.347% |
| Amedisys, Inc. | 2.06 Billion USD | 98.274% |
| American Oncology Network, Inc. | 374.45 Million USD | 90.503% |
| Astrana Health, Inc. | 933.36 Million USD | 96.19% |
| Aveanna Healthcare Holdings Inc. | 1.63 Billion USD | 97.828% |
| IMAC Holdings, Inc. | 1.14 Million USD | -3008.335% |
| biote Corp. | 155.29 Million USD | 77.1% |
| Cryo-Cell International, Inc. | 61.22 Million USD | 41.91% |
| Cross Country Healthcare, Inc. | 679.31 Million USD | 94.765% |
| COMPASS Pathways plc | 275.98 Million USD | 87.114% |
| DocGo Inc. | 490.45 Million USD | 92.749% |
| The Ensign Group, Inc. | 4.17 Billion USD | 99.149% |
| Healthcare Services Group, Inc. | 803.18 Million USD | 95.572% |
| InnovAge Holding Corp. | 547.66 Million USD | 93.506% |
| Assure Holdings Corp. | 7.51 Million USD | -373.29% |
| The Joint Corp. | 87.15 Million USD | 59.194% |
| LifeStance Health Group, Inc. | 2.23 Billion USD | 98.408% |
| Mobile-health Network Solutions Class A Ordinary Shares | 7.95 Million USD | -347.299% |
| ModivCare Inc. | 1.76 Billion USD | 97.988% |
| NewGenIvf Group Limited | 1.64 Million USD | -2058.659% |
| Option Care Health, Inc. | 3.32 Billion USD | 98.932% |
| P3 Health Partners Inc. | 860.96 Million USD | 95.869% |
| P3 Health Partners Inc. | 860.96 Million USD | 95.869% |
| The Pennant Group, Inc. | 539.69 Million USD | 93.41% |
| Surgery Partners, Inc. | 7.01 Billion USD | 99.493% |
| Syra Health Corp. Class A Common Stock | 4.92 Million USD | -622.344% |
| Talkspace, Inc. | 142.22 Million USD | 74.995% |
| Talkspace, Inc. | 142.22 Million USD | 74.995% |
| The Oncology Institute, Inc. | 219.41 Million USD | 83.792% |
| The Oncology Institute, Inc. | 219.41 Million USD | 83.792% |